CA-PACKETFABRIC
9.2.2021 15:02:09 CET | Business Wire | Press release
PacketFabric , an innovator of on-demand connectivity for enterprise customers to the secure private internet, today announced a strategic partnership with Colt Technology Services, a leading provider of global high bandwidth connectivity solutions. This partnership sees Colt’s On Demand offering being directly integrated with PacketFabric’s Network-as-a-Service (NaaS) platform, initially enabling PacketFabric’s enterprise customers to benefit from real-time network connectivity to 100 key data center locations across Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210209005271/en/
PacketFabric’s global customer base can now create private, secure, low latency hybrid cloud and backbone connectivity in minutes, enabled via an API-based software defined interconnection with Colt. Colt’s On Demand platform is underpinned by the Colt IQ Network, which spans more than 29,000 on net buildings and 900 data centers globally, and will significantly increase the reach of PacketFabric’s advanced NaaS platform throughout Europe. Through this integration, PacketFabric’s enterprise customers will be able to benefit from a true SDN experience, which sees services being delivered in real-time via a portal, creating greater agility for the fast-paced business landscape of today.
“When we looked at our European expansion plans, it was clear that Colt was the right strategic partner for PacketFabric,” said Jezzibell Gilmore, PacketFabric Co-founder and Chief Commercial Officer. “Not only is Colt an innovator and pioneer in connectivity services, but they lead the telecom industry in diversity and inclusion. As a women-founded start-up, we are passionate how Colt CEO Keri Gilder has been a champion for women in the telecom and tech industry—so this partnership is personally meaningful for me and my co-founder Anna Claiborne.”
“Colt strives to transform the way the world works through the power of connectivity and this collaboration with PacketFabric will offer enterprise customers the agility and flexibility they need to take on the business challenges of today,” said Keri Gilder, CEO of Colt. “At Colt, we don’t just want to transform how networks are provisioned, we also believe in changing how this sector is viewed and the voices that are heard in it. I am passionate about championing women and I am proud to be partnering with a company created and led by women. I see this collaboration being just an example of how we are innovating and delivering the networks of tomorrow for customers globally.”
“Structure Research’s Global Data Center and Colocation Report reported that EU interconnection will continue to populate and expand, and the market will see significant expansion which bodes well for our partnership and joint enterprise customers,” said Anna Claiborne, PacketFabric Co-founder and SVP Product and Engineering.
The Colt IQ Network connects data centers across Europe, Asia and North America’s largest business hubs. PacketFabric’s Network-as-a-Service platform orchestrates and guarantees connectivity between colocation facilities, clouds, and offers private network interconnection. PacketFabric was recently awarded the “2020 Fierce Telecom Innovation Award for Cloud Services,” a “2020 Cool Vendor in Enhanced Internet Services and Cloud Connectivity” by Gartner and one of the “10 Hottest Networking Startups of 2020” by CRN.
About PacketFabric
PacketFabric redefines how the enterprise moves data by automating network connectivity services. Leveraging an entirely automated SDN-based network architecture and the latest in optical and packet switching technology, PacketFabric enables dynamic, real-time connectivity services between more than hundreds of premier colocation facilities across many global markets. The PacketFabric Network-as-a-Service (NaaS) platform delivers simple, cost-effective, and scalable network deployment via its advanced Application Program Interface (API) and web portal. PacketFabric was named the “2020 Fierce Telecom Innovation Award for Cloud Services,” one of the “10 Hottest Networking Startups of 2020” by CRN and a “2020 Cool Vendor in Enhanced Internet Services and Cloud Connectivity” by Gartner. PacketFabric investors include NantWorks and Digital Alpha Advisors. For more information, visit packetfabric.com .
About Colt
Colt strives to transform the way the world works through the power of connectivity, taking what’s always been in its DNA to enable customers’ success. The Colt IQ Network connects more than 900+ data centers and over 29,000 on net buildings across Europe, Asia and North America’s largest business hubs.
Colt understands today’s shifting connectivity requirements and provides agile, on-demand and secure high bandwidth networking and voice solutions to ensure enterprises can thrive. Customers include data-intensive organizations spanning over 210 cities in more than 30 countries. Colt is a recognized innovator and pioneer in Software Defined Networks (SDN) and Network Function Virtualization (NFV). Privately owned, Colt is one of the most financially sound companies in the sector, and because of this, it’s able to put its customers’ needs at its core. For more information, please visit www.colt.net .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005271/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 16:37:00 CEST | Press release
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory standardsFDA grants Compass NDA rolling submission and review request, based on Phase 3 dataCNPV awarded for COMP360, Compass’ proprietary formulation of synthetic psilocybin, for treatment-resistant depression (TRD)CNPV further accelerates momentum and Compass is confident and ready to deliver for patients Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
